Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid TumorsSolid TumorActive, not recruitingPhase 12025-10-20NCT05627063

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Abbisko Therapeutics Co, Ltd22

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Chongqing University Cancer HospitalChongqingChina33
Comprehensive Cancer Centers of NevadaLas VegasUnited States3
Fujian Cancer Hospital (Department of Hepatobiliary and Pancreatic Oncology /Phase I Ward)FuzhouChina1
Gabrail Cancer Center ResearchCantonUnited States26
Harbin Medical University Cancer Hospital (Gastroenterology Department 2nd Ward)HaerbinChina1
Hubei Cancer HospitalWuhanChina32
Hunan Central HospitalChangshaChina1
Jilin Cancer HospitalChangchunChina24
Karmanos Cancer InstituteDetroitUnited States153
Liaoning Cancer Hospital (Phase I Ward)ShenyangChina1
Mianyang Central HospitalMianyangChina9
Shanghai East Hospital Tongji UniversityShanghaiChina2
Shanxi Provincial Cancer HospitalTaiyuanChina5
The Affiliated Hospital of Inner Mongolia Medical UniversityHohhotChina10
The First Affiliated Hospital of Henan University of Science & TechnologyLuoyangChina14
The First Affiliated Hospital of Nanchang UniversityNanchangChina77
The First Affiliated Hospital of Zhengzhou UniversityZhengzhouChina103
The First Hospital of China Medical UniversityShenyangChina42
UC San Diego Moores Cancer CenterLa JollaUnited States199
West China School of Medicine/West China Hospital of Sichuan UniversityChengduChina3
Yantai Yuhuangding Hospital (Department of Medical Oncology, 1)YantaiChina1
Zhejiang University Cancer HospitalHangzhouChina1
Zhongshan Hospital of Fudan University (Hepatological Surgery Department)ShanghaiChina1
Zhongshan Hospital of Fudan University (Medical Oncology Department)ShanghaiChina1